NewsRSS2 days ago
A patient with AATD (a rare lung disease caused by low levels of a protective protein) shares her personal experiences with complementary and alternative medicine approaches. She discusses how nontraditional treatments have fit into her overall care plan alongside standard medical treatment. The article reflects one patient's perspective on combining different types of medicine to manage her condition.
WHY IT MATTERSPatients with AATD can learn from one person's real-world experience balancing conventional treatment with complementary approaches, which may help inform their own conversations with their healthcare team about what options exist.
ResearchRSS3 days ago
Scientists found that a gene called RUNX1 might help doctors predict when patients with pulmonary arterial hypertension (PAH) — a serious lung disease that makes it hard to pump blood — could develop heart problems. When the right side of the heart weakens in PAH patients, it becomes very dangerous. This discovery could help doctors catch and treat these heart problems earlier.
WHY IT MATTERSIf RUNX1 becomes a validated biomarker, PAH patients could receive earlier interventions to prevent right heart failure, potentially improving survival and quality of life before irreversible damage occurs.
NewsRSS3 days ago
A patient with AATD (Alpha-1 Antitrypsin Deficiency) found personal inspiration by watching the movie Top Gun: Maverick, discovering parallels between the fighter pilot's perseverance and their own journey managing a chronic lung disease. The article explores how popular culture can provide emotional support and motivation for people living with rare diseases. This is a personal reflection piece rather than medical news.
WHY IT MATTERSFor AATD patients, finding relatable stories and sources of inspiration in everyday media can help combat the isolation and emotional burden of managing a progressive genetic lung disease.
NewsRSS3 days ago
This article is a quiz about nerandomilast, a medicine being studied to treat progressive pulmonary fibrosis (PPF), which is a lung disease where lung tissue becomes scarred and stiff over time, making it harder to breathe. The quiz helps patients and caregivers learn more about this potential treatment option. It's a way to test your understanding of how this medicine might help people with this serious lung condition.
WHY IT MATTERSPatients with progressive pulmonary fibrosis have limited treatment options, so learning about emerging therapies like nerandomilast helps them stay informed about potential new ways to slow lung damage.
NewsRSS3 days ago
A person who used to work as a nutrition counselor shares what it's really like to have a good day while living with AATD (alpha-1 antitrypsin deficiency). The article shows how much planning, careful decisions, and inner strength it takes to manage this rare lung disease day-to-day. Even on good days, people with AATD have to think carefully about their choices and energy levels.
WHY IT MATTERSThis firsthand account helps patients and caregivers understand that managing AATD requires constant invisible effort, which can validate their own experiences and help them feel less alone.
AdvocacyRSS3 days ago
This article uses the excitement of NASA's Artemis II space mission as inspiration to encourage big dreams about finding a cure for pulmonary hypertension, a serious lung disease that affects blood vessels. The author draws a parallel between humanity's ability to reach for the stars and the hope that patients with pulmonary hypertension should have for breakthrough treatments. The piece is motivational rather than reporting on specific medical news or research developments.
WHY IT MATTERSThis article may resonate emotionally with pulmonary hypertension patients by framing their disease journey within a larger narrative of human achievement and possibility, though it does not announce any new treatments, trials, or clinical developments.
ResearchRSS3 days ago
Researchers found that data from smartphones and wearable devices, collected over several years through a health app, can help doctors identify people with a rare lung disease called idiopathic pulmonary arterial hypertension (IPAH) earlier than before. The study used information like heart rate and activity levels from the My Heart Counts app to spot differences between people with IPAH and healthy people. This discovery could lead to faster diagnosis of this serious condition.
WHY IT MATTERSEarlier detection of IPAH could allow patients to start treatment sooner, potentially slowing disease progression and improving outcomes for this condition that currently has no cure.
NewsRSS3 days ago
A person with pulmonary hypertension (PH), a rare lung disease that makes it hard for the heart to pump blood through the lungs, shares what it was like growing up with this condition. They had to frequently miss school and explain their illness to classmates who asked questions about their absences. This article highlights the social and emotional challenges that young people with chronic rare diseases face alongside their medical treatment.
WHY IT MATTERSPatients with pulmonary hypertension and their families can find validation and community in peer experiences, while healthcare providers gain insight into the psychosocial impact of PH that extends beyond physical symptoms.
AdvocacyRSS3 days ago
A mother shares her personal story about being diagnosed with pulmonary hypertension three months after giving birth to her second son in 2023. The article focuses on how she manages her condition while raising three boys and the emotional impact this serious lung disease has had on her life and family.
WHY IT MATTERSPatient stories about pulmonary hypertension help newly diagnosed patients and families understand that others are managing this serious condition while maintaining family life, which can provide hope and practical insights into daily living with the disease.
NewsUNITERAREApr 3
The PAN Foundation's financial assistance program for idiopathic pulmonary fibrosis (a lung disease where lung tissue becomes scarred and stiff over time) is currently closed and is not accepting new applications. This program previously offered up to $12,000 per year to help patients pay for treatment costs. The fund status changed on April 2, 2026.
WHY IT MATTERSIf you have idiopathic pulmonary fibrosis and need help paying for medications or treatment, you cannot currently apply to this specific PAN Foundation program, so you'll need to explore other financial assistance options.
ResearchPUBMEDMar 26
Doctors who treat children with rare lung diseases in German-speaking countries were surveyed about their experience and confidence in diagnosing and treating these conditions. The study found that while common rare lung diseases like cystic fibrosis have good support systems, many other rare lung diseases don't have clear treatment guidelines. Researchers want to understand what training and resources doctors need to better help children with these uncommon lung problems.
WHY IT MATTERSIf you have a child with a rare lung disease, this research could lead to better training for pediatric lung doctors in your region, potentially reducing diagnostic delays and improving access to specialized care.
ResearchPUBMEDMar 26
Doctors found a rare lung disease called pulmonary light chain deposition disease (PLCDD) that creates cysts and bumps in the lungs. This disease is hard to diagnose because it looks similar to other lung conditions, but special imaging scans and blood tests for abnormal proteins can help identify it. The article explains how doctors should think about this disease when patients have unusual cyst patterns in their lungs.
WHY IT MATTERSIf you have been diagnosed with an unusual cystic lung disease that doesn't fit typical patterns, your doctor should consider testing for light chain deposition disease, which requires specific blood work and imaging to confirm.
Clinical trialCLINICALTRIALSMar 26
Doctors are building a national database to collect information from 500 patients with pulmonary alveolar proteinosis (PAP), a rare lung disease. This registry will help researchers better understand PAP, improve how doctors diagnose it, and test new treatments. Patients who join will have a voice in deciding what research gets done.
WHY IT MATTERSThis is an active recruitment opportunity for PAP patients to directly influence research priorities and gain access to new diagnostic tests and experimental therapies being evaluated through the registry.
ResearchCLINICALTRIALSMar 26
Researchers at the National Heart, Lung, and Blood Institute are collecting blood and tissue samples from up to 10,000 people to study rare genetic diseases. They want to understand what causes these diseases by examining the samples in a lab. People of any age with undiagnosed or heart and lung diseases can participate. Samples can be collected at the NIH Clinical Center or through your own doctor.
WHY IT MATTERSThis biorepository is actively recruiting and could help researchers identify the genetic causes of your undiagnosed condition, potentially leading to better treatments and diagnosis methods for rare diseases.